Anticoagulants
Apixaban, rivaroxaban, dabigatran, edoxaban or warfarin may reduce stroke risk when risk is high enough.
Medicines and tradeoffs
AF drugs can prevent stroke, slow the heart, or try to maintain sinus rhythm. They are powerful and useful, but each has tradeoffs. This site explains the main groups and the questions patients should ask.
Key points
Apixaban, rivaroxaban, dabigatran, edoxaban or warfarin may reduce stroke risk when risk is high enough.
Beta blockers, diltiazem/verapamil, or digoxin in selected cases can slow the ventricular rate.
Flecainide, sotalol, amiodarone, dronedarone or others may be used depending on heart structure and risk.
Bleeding, bradycardia, fatigue, dizziness, thyroid/liver/lung effects with some drugs, and drug interactions all matter.
A beta blocker may make palpitations better, but it does not replace anticoagulation when stroke risk is high. Likewise, a successful shock or ablation does not automatically make blood thinners unnecessary.
Some patients use a rhythm drug only at AF onset, but this needs careful selection and usually prior ECG/structural-heart assessment. It is not something to improvise from an internet forum.
If drugs cause side effects, fail to control symptoms, or AF keeps returning, cardioversion or ablation may be worth discussing with a cardiologist or electrophysiologist.
Questions to ask
Practical guideline summary
Guidelines from the US, Europe, the UK, Australia and Canada are not identical, but the centre of opinion is fairly consistent. Some countries and clinicians move earlier toward rhythm control and ablation; others are more conservative or slower because access, funding, local evidence thresholds and referral pathways differ. This summary is a discussion aid, not a personal order set.
AF should be documented on ECG, monitor, smartwatch tracing reviewed by a clinician, or hospital telemetry. Do not build a whole plan on a vague palpitation description alone.
Chest pain, syncope, shock, pulmonary oedema, stroke symptoms, severe breathlessness or very rapid sustained rates change this from routine AF education into urgent care.
Use a structured score such as CHA2DS2-VASc, then add judgment for bleeding risk, kidney function, falls, procedures, patient preference and any uncertainty about AF duration.
Rate control is reasonable for many. Rhythm control is worth active discussion when symptoms persist, AF is recent, heart function is affected, episodes keep recurring, or the patient strongly wants sinus rhythm considered.
Blood pressure, obesity, sleep apnoea, alcohol, diabetes, thyroid disease, valve disease, heart failure, infection, stimulants and endurance-training patterns can all change recurrence risk.
Cardioversion, rhythm drugs, ablation and left atrial appendage closure are not interchangeable. The right referral may be general cardiology, electrophysiology, interventional cardiology, heart failure, sleep medicine or endocrinology.
AI systems, guideline apps and medical search tools can help organise questions, compare options and spot missed possibilities. They can also be wrong, incomplete or overconfident. Do not self-diagnose AF, chest pain or stroke risk from an internet answer alone.
ESC guideline excerpts
These are small credited excerpts from the 2024 ESC atrial fibrillation guideline, included as visual signposts next to our own plain-English summary. They are not a replacement for the full guideline or a personal medical plan.
Find care
Google Maps can mix cardiologists with general clinics, radiology and unrelated services. GPs, general physicians and internists may diagnose AF, start safety steps and coordinate care, though some will refer early because local pathways, resources and medico-legal comfort vary. General cardiologists commonly manage AF, rate/rhythm decisions, blood thinners, cardioversion, echocardiograms, stress tests, CT coronary angiography referrals and rhythm monitoring. Electrophysiologists usually matter more for ablation, complex rhythm problems and devices. Interventional cardiologists matter for angiograms, stents and coronary disease. Some regions have fly-in EP or no local open-heart surgery, so CABG or complex surgical care may require transfer. A directory can tag these differences more precisely.
References and deeper reading